Search Results - ruiqin+wu

1 Results Sort By:
SENP1 Enzymatic Activity Inhibitors for Platinum Resistant Ovarian Cancer
­Ovarian cancer is one of the leading causes of cancer-related deaths in women. The survival rate of ovarian cancer patients is low largely due to platinum-based chemotherapy resistance and lack of alternative regimens. A recent study indicated that Janus tyrosine kinase 2 (JAK2), which activates the signal transducers and activators of transcription...
Published: 7/30/2024   |   Inventor(s): Wenge Zhu, Jing Li, Ruiqin Wu, Yiliang Li
Keywords(s):  
Category(s): Technology Classifications > Therapeutics > Small Molecules